Leaflet VELTIANG 35mg prolonged-release tablets

Product code:
W59130002
Quantity:
100
Indicated for:
angina pectoris
Route of administration:
oral
Substance:
trimetazidine (antihypertensive)
ATC
C01EB15 — Cardiovascular system | Other cardiac preparations
Trimetazidine is a medication primarily used for the treatment of angina pectoris (chest pain caused by reduced blood flow to the heart) and other ischemic heart conditions. It works by optimizing the energy metabolism of myocardial cells (heart cells) under conditions of reduced oxygen supply, thereby protecting the heart from the effects of ischemia.

Trimetazidine is used to reduce the frequency and severity of angina episodes, improving exercise tolerance and the quality of life for patients. It may also be used as an adjunct therapy in other conditions involving tissue ischemia.

Side effects are generally rare but may include dizziness, nausea, headaches, or, in very rare cases, tremors or muscle stiffness. It is important to take the medication as prescribed by a doctor and avoid abrupt discontinuation of treatment.

General data about VELTIANG 35mg

Substance:
trimetazidine
Date of latest medicines list:
01-07-2013
Product code:
W59130002
Concentration:
35mg
Pharmaceutical form:
prolonged-release tablets
Quantity:
100
Product type:
Generic medicine
Prescription status:
P-6L — Medicines dispensed with a medical prescription that is not retained by the pharmacy and may be renewed; the prescription may be used for 6 months from the date of issue.

Concentrations available for trimetazidine

  • 20mg
  • 20mg/ml
  • 35mg
  • 40mg
  • 80mg